Protein surface cysteine residues (Cys)

Protein surface cysteine residues are specific amino acid sites characterized by a reactive thiol (-SH) group located on the solvent-accessible surface of a protein [1]. While not a single protein target, these residues are critical in drug discovery as they serve as the primary attachment points for covalent inhibitors, which form irreversible bonds to enhance potency and selectivity [1, 2]. Biologically, surface cysteines play vital roles in redox signaling, enzymatic catalysis, and maintaining protein tertiary structure through disulfide bond formation [2]. In disease contexts, particularly oncology, specific cysteine mutations or conserved cysteines in kinase domains are exploited to develop targeted therapies [3, 4]. For example, the KRAS G12C mutation provides a unique nucleophilic cysteine that allows for the selective inhibition of a previously undruggable protein [3]. Similarly, Ibrutinib targets a specific cysteine (C481) in Bruton's tyrosine kinase to treat B-cell malignancies [4]. However, targeting these residues poses significant therapeutic challenges, including potential off-target reactivity with the broader cysteine proteome [1]. Such non-specific interactions can lead to toxicity, protein haptenization, and subsequent immune-mediated adverse effects [1, 2]. Citations: [1] Singh, J., et al. (2011). Nature Reviews Drug Discovery. [2] Backus, K. M., et al. (2016). Nature. [3] Canon, J., et al. (2019). Nature. [4] Pan, Z., et al. (2007). ChemMedChem.

Other names

Surface-exposed cysteinesReactive cysteinesNucleophilic cysteinesCysteine thiolsSolvent-accessible cysteines

Covalent modification via Michael addition or other electrophilic reactions between a drug's reactive warhead and the nucleophilic thiol group of the cysteine residue [1, 2].